Paeds Cases · cardiology
Explain a pulmonary hypertension diagnosis to an adolescent and family — OSCE
OSCE communication and counselling station: explaining a new diagnosis of pulmonary arterial hypertension to a teenager and their family, outlining the combination therapy, the lifelong nature of the treatment, and the protected transition to adult care, in plain language while addressing fear and adherence.
On this page & tools
Target exams
Counselling framework
Begin by acknowledging the fear and the shock. The collapse was frightening, the diagnosis is a lot to absorb, and the family needs to feel heard before they can hear the plan. Use plain language throughout, avoid jargon, and check understanding at each step. [1] [2]
Explain the condition in terms the family can hold. The blood vessels from the heart to the lungs have become narrowed, so the right side of the heart pumps harder, and that is why the fainting happened during running. The drugs are designed to open those vessels and to take the load off the right side of the heart. Three families of drugs are used together because they work on three different signals that narrow the vessels. [4] [10]
Address the questions directly. This is not a death sentence — the modern combination therapy has changed the outlook substantially, and most children feel much better once the drugs take effect. Competitive and contact sport is generally avoided, but supervised exercise is encouraged and is good for the heart and the body. A transplant is the option held in reserve for the small number who do not respond, and it is not the expected course for someone starting therapy now. [4] [2]
Close on the adherence and the lifelong nature. The medicines work only while they are taken, and stopping them lets the disease return silently, so the routine matters every day. The care is shared with a specialist team, the appointments are regular, and the structured transition to the adult service happens in the late teens so the care continues without a gap. Offer a written summary, a follow-up appointment, and the contact for the specialist nurse. [1] [4]
You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References4Show ledgerHide ledger
- [1]Abman SH, Hansmann G, Archer SL, et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation, 2015.PMID 26534956
- [2]Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J, 2019.PMID 30545978
- [4]Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension. J Heart Lung Transplant, 2019.PMID 31495407
- [10]Barst RJ, Ivy DD, Gaitan G, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation, 2012.PMID 22128226